Stocks and Investing Stocks and Investing
Mon, July 17, 2017
[ 12:00 AM ] - United States, WOPRAI
Jessica Reif Cohen Initiated (ATUS) at Hold and Held Target at $36 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Jason Bazinet Initiated (ATUS) at Strong Buy and Held Target at $44 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Jonathan Atkin Initiated (ATUS) at Buy and Held Target at $40 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Brett Feldman Initiated (ATUS) at Hold and Held Target at $33 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Craig Hettenbach Maintained (AVGO) at Buy with Increased Target to $29 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
David Amsellem Downgraded (SUPN) to Hold on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Michael Blum Upgraded (TRGP) to Buy on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Gregg Gilbert Maintained (BMY) at Hold with Increased Target to $55 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Steven Chubak Maintained (C) at Strong Buy with Increased Target to $78 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Susan Roth Katzke Maintained (C) at Buy with Increased Target to $72 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Amit Singh Upgraded (CACI) to Strong Buy on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Steve Beuchaw Maintained (ALGN) at Buy with Increased Target to $182 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Rajeev Lalwani Maintained (ALK) at Buy with Decreased Target to $102 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Gabriela Borges Initiated (ANSS) at Hold and Held Target at $112 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Vincent Caintic Downgraded (ALLY) to Sell on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (ZBH) at Buy with Increased Target to $150 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Gregg Gilbert Maintained (ZTS) at Strong Buy with Increased Target to $65 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Rajeev Lalwani Maintained (AAL) at Hold with Increased Target to $54 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Howard Rubel Downgraded (BAH) to Hold on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Seth Weber Upgraded (URI) to Buy on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
David Glick Initiated (VFC) at Hold and Held Target at $55 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Increased Target to $46 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Holford Maintained (ABBV) at Strong Buy with Increased Target to $94 on, Jul 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Gregg Gilbert Maintained (ABBV) at Hold with Increased Target to $66 on, Jul 17th, 2017
Fri, July 14, 2017
[ 12:00 AM ] - United States, WOPRAI
Chris Kotowski Maintained (APO) at Buy with Increased Target to $33 on, Jul 14th, 2017
[ 12:00 AM ] - United States, WOPRAI
Peter Lawson Initiated (AFMD) at Strong Buy and Held Target at $70 on, Jul 14th, 2017
[ 12:00 AM ] - United States, WOPRAI
Seth Seifman Upgraded (BA) to Buy on, Jul 14th, 2017
[ 12:00 AM ] - United States, WOPRAI
Matthew Niknam Maintained (AMT) at Strong Buy with Increased Target to $157 on, Jul 14th, 2017
[ 12:00 AM ] - United States, WOPRAI
Lynne Collier Upgraded (BJRI) to Strong Buy on, Jul 14th, 2017
[ 12:00 AM ] - United States, WOPRAI
Ken Trbovich Initiated (SUPN) at Hold and Held Target at $47 on, Jul 14th, 2017

Ken Trbovich Initiated (SUPN) at Hold and Held Target at $47 on, Jul 14th, 2017


Published on 2024-10-25 21:38:58 - WOPRAI, Ken Trbovich
  Print publication without navigation


Ken Trbovich of Janney Montgomery Scott, Initiated "Supernus Pharmaceuticals, Inc." (SUPN) at Hold and Held Target at $47 on, Jul 14th, 2017.

Ken has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with Ken's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ken

  • David Amsellem of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $44 on, Thursday, June 1st, 2017

Contributing Sources